Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LABORATORY CORPORATION OF AMERICA

NPI: 1821073792 · SAN ANTONIO, TX 78233 · Clinical Medical Laboratory · NPI assigned 12/13/2005

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more

$11.67M
Total Medicaid Paid
568,649
Total Claims
511,985
Beneficiaries
46
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialWILLIAMS, KIMBERLY (VP)
NPI Enumeration Date12/13/2005

Related Entities

Other providers sharing the same authorized official: WILLIAMS, KIMBERLY

ProviderCityStateTotal Paid
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $1.44B
LABORATORY CORPORATION OF AMERICA HOLDINGS RARITAN NJ $717.47M
LABORATORY CORPORATION OF AMERICA HOLDINGS DUBLIN OH $617.02M
LABORATORY CORPORATION OF AMERICA HOLDINGS BIRMINGHAM AL $289.12M
LABORATORY CORPORATION OF AMERICA PHOENIX AZ $265.90M
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $264.26M
LABORATORY CORPORATION OF AMERICA HOLDINGS CHARLESTON WV $220.04M
LABORATORY CORPORATION OF AMERICA SEATTLE WA $186.69M
LABORATORY CORPORATION OF AMERICA TAMPA FL $171.13M
LABORATORY CORPORATION OF AMERICA SAN DIEGO CA $147.14M
LABORATORY CORPORATION OF AMERICA HOUSTON TX $103.81M
LABORATORY CORPORATION OF AMERICA ENGLEWOOD CO $77.80M
LABORATORY CORPORATION OF AMERICA DALLAS TX $77.42M
LABORATORY CORPORATION OF AMERICA BURLINGTON NC $59.75M
MEDTOX LABORATORIES, INC SAINT PAUL MN $47.72M
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $15.65M
TRI-CITIES LABORATORY, LLC KENNEWICK WA $8.69M
LABORATORY CORPORATION OF AMERICA HOLDINGS MONROE LA $3.39M
LABORATORY CORPORATION OF AMERICA ITASCA IL $3.37M
LABORATORY CORPORATION OF AMERICA ALBANY NY $2.06M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 157,681 $3.28M
2019 138,817 $2.92M
2020 199,149 $4.13M
2021 68,187 $1.32M
2022 1,097 $11K
2023 1,993 $8K
2024 1,725 $4K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 139,008 125,331 $3.19M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 138,413 124,672 $3.18M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 92,944 81,951 $2.17M
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 82,768 74,234 $1.37M
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 46,113 41,302 $1.01M
88141 13,448 12,888 $199K
88142 13,255 12,341 $187K
87625 2,734 2,419 $68K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 4,240 3,953 $59K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,102 1,010 $46K
87150 2,029 1,957 $40K
87086 Culture, bacterial; quantitative colony count, urine 6,231 5,749 $31K
87081 3,296 3,182 $13K
86696 901 819 $12K
86592 4,229 3,921 $11K
80074 466 370 $9K
86803 795 748 $7K
87088 1,339 1,249 $7K
82247 2,050 1,597 $6K
87529 286 268 $6K
82248 2,023 1,574 $6K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 102 100 $6K
86695 683 623 $6K
87186 907 848 $5K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 86 80 $4K
87340 618 577 $4K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 16 16 $3K
87077 257 242 $1K
84443 Thyroid stimulating hormone (TSH) 118 105 $1K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 4,871 4,838 $582.17
80053 Comprehensive metabolic panel 73 62 $425.06
85025 Blood count; complete (CBC), automated, and automated differential WBC count 150 122 $415.32
86694 36 36 $374.50
80061 Lipid panel 40 40 $328.04
86780 26 26 $319.45
88112 28 26 $222.95
36415 Collection of venous blood by venipuncture 237 216 $174.09
83036 Hemoglobin; glycosylated (A1C) 33 28 $137.63
86706 15 15 $115.04
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 1,210 1,204 $59.53
85014 23 23 $50.83
85018 23 23 $50.83
36416 1,048 827 $35.00
87210 12 12 $23.90
G0124 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician 337 337 $0.00
99199 Unlisted special service, procedure or report 30 24 $0.00